NASDAQ: GPCR
Structure Therapeutics Inc Stock Ownership - Who owns Structure Therapeutics?

Insider buying vs selling

Have Structure Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Raymond C. StevensCHIEF EXECUTIVE OFFICER2024-06-1250,001$0.48
$24.00kBuy
Raymond C. StevensCHIEF EXECUTIVE OFFICER2024-06-1299,999$0.39
$39.00kBuy
Xichen LinCHIEF SCIENTIFIC OFFICER2024-06-03106,200$0.34
$36.11kBuy

1 of 1

GPCR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GPCR insiders and whales buy or sell their stock.

GPCR Shareholders

What type of owners hold Structure Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wellington Management Group LLP4.53%7,785,614$179.85MInstitution
Fil Ltd3.76%6,473,761$149.54MInsider
Fmr LLC3.53%6,078,746$140.42MInstitution
Fmr LLC3.11%5,345,338$123.48MInsider
Janus Henderson Group PLC2.42%4,159,888$96.09MInstitution
Capital Research Global Investors2.06%3,537,341$81.71MInstitution
Ramy Farid1.90%3,260,495$75.32MInsider
Jun Yoon1.66%2,847,885$65.79MInsider
Deep Track Capital LP1.63%2,800,000$64.68MInstitution
Raymond C. Stevens1.56%2,688,264$62.10MInsider

1 of 3

GPCR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GPCR35.24%12.56%Net Buying
EWTX86.39%13.61%Net BuyingNet Buying
CLDX85.28%14.72%Net Buying
VERA66.31%33.69%Net SellingNet Selling
OCUL78.69%21.31%Net SellingNet Selling

Structure Therapeutics Stock Ownership FAQ

Who owns Structure Therapeutics?

Structure Therapeutics (NASDAQ: GPCR) is owned by 35.24% institutional shareholders, 12.56% Structure Therapeutics insiders, and 52.19% retail investors. Fil Ltd is the largest individual Structure Therapeutics shareholder, owning 6.47M shares representing 3.76% of the company. Fil Ltd's Structure Therapeutics shares are currently valued at $149.16M.

If you're new to stock investing, here's how to buy Structure Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.